loader
Please Wait
Applying Filters...
menu
    • menu

    Company Digital Content of Astral Steritech

    Centrient Pharmaceuticals-PSE
    News
    Enforcement Report - Week of May 24, 2023

    24 May 2023

    // FDA

    Astral`s Generic Cefepime Hydrochloride Receives Approval in US

    29 Jul 2020

    // FDA

    Sagent recalls second lot of antibiotic made by Astral SteriTech

    23 Aug 2016

    // Gareth MacDonald+ IN PHARMATECHNOLOGIST

    Data Compilation
    #PharmaFlow

    Centrient Pharmaceuticals RM

    Contact Supplier

    Website

    26th North American ISSX

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    Menu

    Astral SteriTech

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Explore the latest content creation from this company

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of May 24, 2023
    Enforcement Report - Week of May 24, 2023

    24 May 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-24-2023-89772.pdf

    FDA
    24 May 2023
    Share Share
    Astral`s Generic Cefepime Hydrochloride Receives Approval in US
    Astral`s Generic Cefepime Hydrochloride Receives Approval in US

    29 Jul 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212721

    FDA
    29 Jul 2020
    Share Share
    Sagent recalls second lot of antibiotic made by Astral SteriTech
    Sagent recalls second lot of antibiotic made by Astral SteriTech

    23 Aug 2016

    // Gareth MacDonald+ IN PHARMATECHNOLOGIST

    http://www.in-pharmatechnologist.com/Regulatory-Safety/Sagent-recalls-second-lot-of-antibiotic-made-by-Astral-SteriTech-after-rust-found-in-vial

    Gareth MacDonald+ IN PHARMATECHNOLOGIST
    23 Aug 2016
    Share Share